The role of polyol pathway in high glucose-induced endothelial cell damages

Diabetes Research and Clinical Practice

Volumn 73, Issue 3, 2006, Pages 227-234

  Oyama, Tomokazu ^a   Miyasita, Yoh ^a   Watanabe, Husako ^a   Shirai, Kohji ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aldose reductase inhibitor; Endothelial cell damage; High glucose; Oxidative stress; Polyol pathway

Indexed keywords

CASPASE 3; DNA; DNA FRAGMENT; FIDARESTAT; POLYOL; SORBITOL;

ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GLUCOSE INTAKE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; OXIDATION;

ALDEHYDE REDUCTASE; CARBOHYDRATE METABOLISM; CASPASE 3; CELLS, CULTURED; CULTURE MEDIA; DEOXYGUANOSINE; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GLUCOSE; HUMANS; IMIDAZOLIDINES; POLYMERS; SIGNAL TRANSDUCTION; SORBITOL;

EID: 33746561172     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.02.010     Document Type: Article

References (53)

1. Kannnel W.B., and McGee D.L. Diabetes and cardiovascular disease, the Framingham study. JAMA 241 (1979) 2035-2038
2. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16 (1993) 434-444
3. Sakata N., Meng J., and Takebayashi S. Effect of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells. J. Atheroscler. Thromb. 3 (2000) 169-176
4. Ways D.K., and Sheetz M.J. The role of protein kinase C in the development of the complications of diabetes. Vitam. Horm. 60 (2000) 149-193
5. Mashima R., Witting P.K., and Stocker R. Oxidants and antioxidants in atherosclerosis. Curr. Opin. Lipidol. 4 (2001) 411-418
6. Sakamoto N., Kinoshita J.H., Kador P.F., and Hotta N. Polyol Pathway and its Role in Diabetic Complications (1988), Elsevier Science B.V., Amsterdam
7. Hotta N., and Sakamoto N. Aldose reductase inhibitors. In: Alberti K.G.M.M., and Krall L.P. (Eds). The Diabetes Annual 5 (1990), Elsevier Science B.V., Amsterdam 330-361
8. Naruse K., Nakamura J., Hamada Y., Nakayama M., Chaya S., et al. Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes. Exp. Eye Res. 71 (2000) 309-315
9. Bhatnagar A., and Srivastava S.K. Aldose reductase: congenial and injurious profiles of an enigmatic enzyme. Biochem. Med. Metabol. Biol. 48 (1992) 91-121
10. Kinoshita J.H., and Nishimura C. The involvement of aldose reductase in diabetes complications. Diabetes Metab. Rev. 4 (1988) 323-337
11. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetes complications. Pharmacol. Rev. 50 (1988) 21-33
12. Gabbay K.H. The sorbitol pathway and the complications of diabetes. N. Engl. J. Med. 288 (1973) 831-836
13. Hamada Y., Kitoh R., and Raskin P. Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients. Diabetes 40 (1991) 1233-1240
14. Dent M.T., Tebbs S.E., Gonzalez A.M., Ward J.D., and Wilson R. Neutrophil aldose reductase activity and its association with established diabetic microvascular complications. Diabetes Med. 8 (1991) 439-442
15. Endo T., Iwata N., Inazu N., Hara S., Kano S., Kuriiwa F., et al. Interindividual variability of hepatic carbonyl reductase levels in Japanese. In: Bernhard J., and Bonte W. (Eds). Advancement of Forensic Science (1995), Verlag Chemie, Berlin 27-31
16. Gonzalez R.G., Barnett P., Aguayo J., Cheng H.-M., and Chylack Jr. L.T. Direct measurement of polyol pathway activity in the ocular lens. Diabetes 33 (1984) 196-199
17. Chandra D., Jackson E.B., Ramana K.V., Kelley R., Srivastava S.K., and Bhatnagar A. Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes. Diabetes 51 10 (2002) 3095-3101
18. Greene D.A., Lattimer S.A., and Sima A.A. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 316 5 (1987) 599-606
19. Kinoshita J.H., Merola L.O., Satoh K., and Dikmac E. Osmotic changes caused by accumulation of dulcitol in the lenses of rats fed with galactose. Nature 194 (1962) 1085-1087
20. 2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia 37 (1994) 262-269
21. Williamson J.R., Cheng K., Frangos M., Hasan K.S., Ido Y., Kawamura T., et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42 (1993) 801-813
22. Cameron N.E., and Cotter M.A. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 35 (1992) 1011-1019
23. Mizuno K., Kato N., Matsubara A., Nakano K., and Kurono M. Effects of a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2′,5′-dioxospiro [chroman-4,4′-imidazolidine]-2-carboxamide (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats. Metabolism 41 10 (1992) 1081-1086
24. Jaffe E.A., Nachmann R.I., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52 (1973) 2745-2746
25. Gordon O., Guerrant C., and Moss W. Determination of monosaccharides as aldononitrite, O-methyloxime, alditol, and cyclitol acetate derivatives by gas chromatography. Anal. Chem. 56 (1984) 633-638
26. Wiechelman K., Braun R., and Fitzpatrick J. Investigation of the bicinchoninic acid protein assay: Identification of the groups responsible for color formation. Anal. Biochem. 175 (1988) 231-237
27. Wang X., Zelenski N.G., Yang J., et al. Cleavage of sterol regulatory element binding protein (SREBPs) by CPP32 during apoptosis. EMBO J. 15 (1996) 1012-1020
28. Kumar S. The apoptotic cysteine protease CPP32. Int. J. Biochem. Cell Biol. 29 (1997) 393-396
29. Richter C., Park J.W., and Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 6465-6467
30. Kasai H., Crain P.F., Kuchino Y., Nishimura S., Ootsuyama A., and Tanooka H. Formation of 8-hydroxy-2′-deoxyguanosine moiety in cellular DNA by agents producting oxygen radicals and evidence for its repair. Carcinogenesis 7 (1986) 1849-1851
31. Peppa M., Brem H., Ehrlich P., Zhang J.G., Cai W., and Vlassara H. Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice. Diabetes 52 (2003) 2805-2813
32. Leinonen J., Lehtimaki T., Toyokuni S., Okada K., Tanaka T., Hirai H., et al. New biomarker evidence of oxidative DNA damage in patients with non-insurin-dependent diabetes mellitus. FEBS Lett. 417 (1997) 150-152
33. Toyokuni S., Tanaka T., Hattori Y., Nishiyama Y., Yoshida A., Uchida K., et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab. Invest. 76 (1997) 365-374
34. Malin R., Rantalaiho V., Huang X.H., Wirta O., Pasternack A., Leinonen J.S., et al. Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects. Hum. Genet. 105 (1999) 179-180
35. Mizutani K., Ikeda K., Nishikata T., and Yamori Y. Phytoestrogens attenuate oxidative DNA damage in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. J. Hypertens. 18 (2000) 1833-1840
36. Inoue T., Inoue K., Maeda H., Takayanagi K., and Morooka S. Immunological response to oxidized LDL occurs in association with oxidative DNA damage independently of serum LDL concentrations in dyslipidemic patients. Clin. Chim. Acta 305 (2001) 115-121
37. Barnett P.A., Gonzalez R.G., Chylack Jr. L.T., and Cheng H.M. The effect of oxidation on sorbitol pathway kinetics. Diabetes 35 (1986) 426-432
38. Obrosova I.G., Pacher P., Szabo C., Zsengeller Z., Hirooka H., Stevens M.J., et al. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes 54 (2005) 234-242
39. Mlakar A., Batna A., Dudda A., and Spiteller G. Iro (II) ions induced oxidation of ascorbic acid and glucose. Free Radical Res. 25 (1996) 525-539
40. Wells-Knecht K.J., Zyzak D.V., Litchfield J.E., Thorpe S.R., and Baynes J.W. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry 34 (1995) 3702-3709
41. Shangari N., and O'Brien P.J. The cytotoxic mechanism of glyoxal involves oxidative stress. Biochem. Pharmacol. 68 (2004) 1433-1442
42. Loidl-Stahlhofen A., and Spiteller G. Alpha-hydroxyaldehydes, products of lipid peroxidation. Biochim. Biophys. Acta 1211 (1994) 156-160
43. Shigenaga M.K., Gimeno C.J., and Ames B.N. Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 9697-9701
44. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radical Res. 25 (1996) 57-74
45. Nishikawa T., Sasahara T., Kiritoshi S., Sonoda K., Senokuchi T., Matsuo T., et al. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care 26 (2003) 1507-1512
46. Nakanishi S., Suzuki G., Kusunoki Y., Kimura K., Egusa G., and Kohno N. Increasing of oxidative stress from mitochondria in type 2 diabetic patients. Diabetes Metab. Res. Rev. 20 (2004) 399-404
47. Suzuki S., Hinokio Y., Komatsu K., Ohtomo M., Onoda M., Hirai S., et al. Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. Diabetes Res. Clin. Pract. 45 (1999) 161-168
48. Miyashita Y., Shirai K., Ito Y., Watanabe J., Urano Y., Murano T., et al. Cytotoxicity of some oxysterols on human vascular smooth muscle cells was mediated by apoptosis. J. Atheroscler. Thromb. 4 (1997) 73-78
49. Ramana K.V., Bhatnagar A., and Srivastava S.K. Inhibition of aldose reductase attenuates TNF-alpha-induced expression of adhesion molecules in endothelial cells. FASEB J. 18 (2004) 1209-1218
50. Suzuki T., Sekido H., Kato N., Nakayama Y., and Yabe-Nishimura C. Neurotrophin-3-induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose: involvement of the polyol pathway. J. Neurochem. 91 (2004) 1430-1438
51. Beg A.A., and Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274 (1996) 782-784
52. Wang C.-Y., Mayo M.W., Korneluk R.G., Goeddel D.V., and Baldwin A.S. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281 (1998) 1680-1683
53. Chu Z.-L., McKinsey T.A., Liu L., Gentry J.J., Malim M.H., and Ballard D.W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 10057-10062